Today, Nigeria celebrates with  the global community on World Hearing Day, with the theme,  "From communities to classrooms: hearing care for all children.” ...

Stroke remains one of the leading causes of disability worldwide, with motor impairments having the greatest impact on patients’ quality of life. To make rehabilitation more effective, it is essential ...

Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people with ...

Dusseldorf, Germany, March 5, 2026 - Priavoid GmbH (“Priavoid”) today announced it will present promising initial safety data from the ongoing ...

Today, Nigeria celebrates with the global community on World Hearing Day, with the theme, "From communities to classrooms: hearing care for all children." The campaign focuses on integrating ear and ...

BV100 is a novel intravenous formulation of rifabutin based on the newly identified mode of action for the active uptake of rifabutin into the Acinetobacter baumannii-calcoaceticus complex. BV100 is ...

Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people with this rare, devastating genetic neurodevelopmental disease- -Data support ...

Researchers from the University of Queensland have revealed that the venom of scorpions of the genus Androctonus is able to ...

Claims data point to missed diagnoses, weak documentation and supervision gaps as core exposure themes amid a tougher US liability climate ...

Chronic pain has a personalized "brain fingerprint," allowing AI to decode spontaneous pain levels through fMRI scans.

We are very pleased to have aligned with the FDA on the path forward for our MAGNITUDE clinical trial, with measures designed ...

Ropeginterferon alfa-2b-njft is currently FDA-approved and marketed as BESREMi (R) for the treatment of adults with polycythemia vera (PV). The Company is seeking a ropeginterferon alfa-2b-njft label ...